PeterCMorrisMD

Obstetrics & Gynecology • Lincoln, NE

Gynecologic Oncology

Physician

Join to view full profile

Are you Dr. Morris?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3901 Pine Lake Rd Ste 111
Lincoln, NE 68516
Phone+1 402-420-7000

Fax+1 402-420-6969
Is this information wrong?

Summary

Dr. Peter Morris, MD is an obstetrician/gynecologist in Lincoln, Nebraska. He is currently licensed to practice medicine in Nebraska, Iowa, and Oklahoma. He is affiliated with Bryan Medical Center, CHI Health Creighton University Medical Center - Bergan Mercy, and Nebraska Methodist Hospital.

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1990 - 1992
University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 1985 - 1988
University of New Mexico School of MedicineInternship, Transitional Year, 1983 - 1984
University of Texas Southwestern Medical SchoolClass of 1983

Certifications & Licensure

NE State Medical License 1992 - 2024
IA State Medical License 1990 - 2007
TX State Medical License 1983 - 2005
NC State Medical License 1985 - 1992
OK State Medical License 1986 - 1991
NM State Medical License 1984 - 1988
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2012 Oct 01
Active, not recruiting
Not Applicable
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

61 citations
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve, Jonathan Oh, Devansu Tewari, Peter C. Morris, Erin E. Stevens, Justin N. Bott...> ;The Lancet. Oncology. 2020 Dec 1
Systematic Review and Meta-Analysis of Hypothermic Machine Perfusion Versus Static Cold Storage of Kidney Allografts on Transplant Outcomes
O'Callaghan, J. M.,Morgan, R. D.,Knight, S. R.,Morris, P. J.> ;Wiley. 2013 Jul
11 citations
Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial
David B. Engle, Joseph P. Connor, Peter C. Morris, David Bender, Koen De Geest, Amina Ahmed, Michael J. Goodheart> ;Archives of Gynecology and Obstetrics. 2012 May 9
39 citations
Nonbacterial Thrombotic Endocarditis with Recurrent Embolic Events as Manifestation of Ovarian Neoplasm
Arash Aryana, Dennis J. Esterbrooks, Peter C. Morris> ;Journal of General Internal Medicine. 2006 Dec 1
28 citations
The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer
Christine Goudge, Shana Bernhard, Noelle G Cloven, Peter C. Morris> ;Gynecologic Oncology. 2004 May 1
188 citations
Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision.
James Fanning, H.C.Lois Lambert, Theodore M. Hale, Peter C. Morris, Conrad Schuerch> ;American Journal of Obstetrics and Gynecology. 1999 Jan 1
5 citations
THYROID CANCER COMPLICATING PREGNANCY
Peter C. Morris> ;Obstetrics and Gynecology Clinics of North America. 1998 Jun 1
12 citations
Osmotic lysis of tumor spill in ovarian cancer: A murine model
Peter C. Morris, Valerie Scholten> ;American Journal of Obstetrics and Gynecology. 1996 Dec 1
51 citations
Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix.
Joseph P. Connor, Peter C. Morris, Turgut Alagoz, Barrie Anderson, K Bottles, Richard E. Buller> ;Obstetrics and Gynecology. 1995 Sep 1
23 citations
Steroid Hormone Receptor Content and Lymph Node Status in Endometrial Cancer
Peter C. Morris, James R. Anderson, Barrie Anderson, Richard E. Buller> ;Gynecologic Oncology. 1995 Mar 1
12 citations
The significance of peritoneal cytology in stage IB cervical cancer.
Peter C. Morris, Haugen J, Barrie Anderson, Richard E. Buller> ;Obstetrics and Gynecology. 1992 Aug 1
9 citations
A peripherally implanted permanent central venous access device.
Peter C. Morris, Richard E. Buller, S Kendall, Barrie Anderson> ;Obstetrics and Gynecology. 1991 Dec 1
Join now to see all

Press Mentions

Bryan Health & Cancer Partners of Nebraska Bring New Cancer Specialty to LincolnJanuary 14th, 2022
Researchers Find Gene to Make Barley ‘Drought-Proof’September 2nd, 2019

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Hospital Affiliations

CHI Health Creighton University Medical Center - Bergan MercyOmaha, Nebraska
Avera Creighton HospitalCreighton, Nebraska
Nebraska Methodist HospitalOmaha, Nebraska
Bryan Medical CenterLincoln, Nebraska